Venous thromboembolic diseases: diagnosis, management and thrombophilia testing
KEYWORDS: people, treatment, anticoagulation, dvt, committee, anticoagulation treatment, evidence, vte, recommendations, risk, cancer, agreed, clinical, use, d-dimer

for the treatment of suspected DVT or PE. See NICE's information on prescribing medicines. 1.3.4 When using interim therapeutic anticoagulation for suspected proximal DVT or PE: • carry out baseline blood tests including full blood count, renal and hepatic function, prothrombin time (PT) and activated partial thromboplastin time (APTT) • do not wait for the results of baseline blood tests before starting anticoagulation treatment • review, and if necessary act on, the results of baseline blood tests within 24 hours of starting interim therapeutic anticoagulation. [2020] Anticoagulation treatment for confirmed DVT or PE 1.3.5 Offer anticoagulation treatment for at least 3 months to people with confirmed proximal DVT or PE. For recommendations on treatment after 3 months, see the section on long-term anticoagulation for secondary prevention. [2020] 1.3.6 If not already done, carry out baseline blood tests, as outlined in recommendation 1.3.4, when starting anticoagulation treatment. [2020] 1.3.7 When offering anticoagulation treatment, take into account comorbidities, contraindications and the person's preferences. Follow the recommendations on anticoagulation treatment in the sections on: • DVT or PE in people at extremes of body weight • PE with haemodynamic instability • DVT or PE with renal impairment or established renal failure • DVT
